A carregar...
A Review and Analysis of the YODA Trials: What Can We Glean Clinically?
Medtronic’s biologic, Infuse (rhBMP-2), was approved by the FDA in 2002. Since its approval, a whirlwind of controversy developed culminating in an investigation by the Senate Finance committee. These events led to a landmark agreement between Medtronic and Yale University to perform a comprehensive...
Na minha lista:
| Publicado no: | Curr Rev Musculoskelet Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer US
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4596165/ https://ncbi.nlm.nih.gov/pubmed/24903374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12178-014-9220-4 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|